INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 259 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,068 | +13.3% | 27,960 | +21.9% | 0.01% | +16.7% |
Q2 2023 | $943 | -52.2% | 22,935 | -33.2% | 0.01% | -53.8% |
Q1 2023 | $1,972 | +3.5% | 34,348 | +1.1% | 0.01% | -7.1% |
Q4 2022 | $1,905 | -99.9% | 33,983 | -17.1% | 0.01% | +7.7% |
Q3 2022 | $1,736,000 | +169.1% | 40,989 | +243.4% | 0.01% | +225.0% |
Q2 2022 | $645,000 | -32.7% | 11,935 | -20.0% | 0.00% | -20.0% |
Q1 2022 | $958,000 | +2.2% | 14,911 | +6.6% | 0.01% | +25.0% |
Q4 2021 | $937,000 | +21.1% | 13,987 | +23.7% | 0.00% | 0.0% |
Q3 2021 | $774,000 | +19.6% | 11,305 | +19.2% | 0.00% | 0.0% |
Q2 2021 | $647,000 | +15.7% | 9,488 | +17.4% | 0.00% | +33.3% |
Q1 2021 | $559,000 | +30.0% | 8,085 | +22.1% | 0.00% | 0.0% |
Q4 2020 | $430,000 | -25.6% | 6,624 | -24.5% | 0.00% | -25.0% |
Q3 2018 | $578,000 | -33.6% | 8,772 | -35.2% | 0.00% | -33.3% |
Q2 2018 | $871,000 | +13.4% | 13,529 | -2.6% | 0.01% | +20.0% |
Q1 2018 | $768,000 | -25.1% | 13,885 | -35.1% | 0.01% | -28.6% |
Q4 2017 | $1,025,000 | +308.4% | 21,407 | +330.5% | 0.01% | +250.0% |
Q3 2017 | $251,000 | -2.3% | 4,973 | +5.4% | 0.00% | 0.0% |
Q2 2017 | $257,000 | +24.8% | 4,719 | +96.3% | 0.00% | +100.0% |
Q4 2016 | $206,000 | -22.8% | 2,404 | -25.5% | 0.00% | -50.0% |
Q3 2016 | $267,000 | -88.7% | 3,229 | -89.1% | 0.00% | -87.5% |
Q2 2016 | $2,357,000 | +862.0% | 29,538 | +712.2% | 0.02% | +700.0% |
Q1 2016 | $245,000 | +34.6% | 3,637 | +35.2% | 0.00% | +100.0% |
Q4 2015 | $182,000 | -14.6% | 2,691 | -24.8% | 0.00% | -50.0% |
Q3 2015 | $213,000 | +208.7% | 3,577 | +250.3% | 0.00% | +100.0% |
Q2 2015 | $69,000 | -93.6% | 1,021 | -94.2% | 0.00% | -87.5% |
Q1 2015 | $1,083,000 | +2418.6% | 17,570 | +2112.8% | 0.01% | – |
Q4 2014 | $43,000 | -6.5% | 794 | -15.2% | 0.00% | – |
Q3 2014 | $46,000 | +7.0% | 936 | +1.6% | 0.00% | – |
Q2 2014 | $43,000 | +2.4% | 921 | 0.0% | 0.00% | – |
Q1 2014 | $42,000 | -6.7% | 921 | -2.3% | 0.00% | – |
Q4 2013 | $45,000 | -59.1% | 943 | -65.4% | 0.00% | -100.0% |
Q3 2013 | $110,000 | +111.5% | 2,728 | +90.8% | 0.00% | – |
Q2 2013 | $52,000 | – | 1,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |